Compare CART & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CART | CRL |
|---|---|---|
| Founded | 2012 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 8.3B |
| IPO Year | 2023 | 1999 |
| Metric | CART | CRL |
|---|---|---|
| Price | $36.25 | $169.90 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 23 | 12 |
| Target Price | $52.61 | ★ $199.64 |
| AVG Volume (30 Days) | ★ 5.9M | 1.1M |
| Earning Date | 05-14-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 112.71 | N/A |
| EPS | ★ 1.30 | N/A |
| Revenue | ★ $3,378,000,000.00 | $1,857,601,000.00 |
| Revenue This Year | $12.19 | $2.51 |
| Revenue Next Year | $9.50 | $4.66 |
| P/E Ratio | $27.88 | ★ N/A |
| Revenue Growth | ★ 11.05 | 10.48 |
| 52 Week Low | $32.73 | $91.86 |
| 52 Week High | $53.50 | $228.88 |
| Indicator | CART | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 42.43 | 32.93 |
| Support Level | $32.73 | $146.33 |
| Resistance Level | $39.70 | $164.36 |
| Average True Range (ATR) | 1.72 | 10.68 |
| MACD | 0.29 | -3.27 |
| Stochastic Oscillator | 41.03 | 27.56 |
Maplebear (Instacart) is a grocery-focused delivery marketplace that connects national and regional grocers with consumers and couriers, and consumers with their favorite stores. Its app provides on-demand convenience for consumers, allows couriers to earn income, and helps grocers to scale their business through digital channels. The marketplace gathers valuable consumer behavior data, attracting consumer-packaged-goods advertisers that seek to reach consumers at the point of purchase. With approximately 600,000 shoppers and 1,800 retail partners, Instacart delivers to about 98% of households in the United States and Canada.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.